ADIL vs ALLE · $6.0M cap vs P/E 21, rev $2.19B
Adial Pharmaceuticals Inc (ADIL) versus Allegion PLC (ALLE) — a side-by-side from cached financials, not a winner call.
Adial Pharmaceuticals Inc (ADIL) is a biotechnology company listed on NASDAQ.
Allegion PLC (ALLE) is a security & protection services company listed on US.
ADIL does not have a complete income-statement cache yet.
Latest reported ALLE revenue for 2026-06-30 was $2.19B. Net income was $322.7M. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
ADIL currently screens at market cap $6.0M. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
Not investment advice. Open the ADIL and ALLE stock pages for the full models.
Not investment advice.